Valuation: Balchem Corporation

Market Cap 5.47B 4.87B 4.51B 4.09B 7.69B 517B 7.79B 54.02B 21.2B 271B 20.52B 20.09B 865B P/E 2026 *
31.8x
P/E 2027 * 30.5x
Enterprise Value 5.51B 4.9B 4.54B 4.11B 7.74B 520B 7.84B 54.37B 21.33B 273B 20.65B 20.22B 870B EV / Sales 2026 *
4.87x
EV / Sales 2027 * 4.54x
Free-Float
99.51%
Yield 2026 *
0.68%
Yield 2027 * 0.76%
1 day-0.49%
1 week+0.62%
Current month+3.53%
1 month+2.23%
3 months+4.79%
6 months-3.80%
Current year+11.36%
1 week 169.72
Extreme 169.7152
174.29
1 month 161.05
Extreme 161.0501
174.29
Current year 152.58
Extreme 152.58
183.9
1 year 147.18
Extreme 147.18
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 67.71
Extreme 67.71
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
1/4/26 Other

Controller/Auditor

8,646 0.0270%
11/2/26 Free

Director

870 0.0027%
11/2/26 Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%+0.62%+13.27%+39.45% 5.47B
-0.02%+0.85%+2.83%+80.14% 80.78B
+0.05%+3.80%+11.14%+38.05% 44.31B
+0.65%+5.21%+5.78%-14.42% 35.88B
-0.86%+3.06%+8.72%+16.97% 33.86B
+0.78%+5.45%+13.28%+65.11% 32.42B
+0.98%-0.50%-4.85%+20.11% 25.39B
+0.73%+3.59%+57.94%+49.37% 25.21B
+0.90%+3.55%-44.76%-38.75% 17.96B
-2.68%-6.99%+32.25%+13.06% 17.15B
Average +0.00%+1.84%+9.56%+26.91% 31.84B
Weighted average by Cap. +0.10%+2.18%+8.84%+37.14%

Financials

2026 *2027 *
Net sales 1.13B 1.01B 933M 845M 1.59B 107B 1.61B 11.17B 4.38B 56.15B 4.24B 4.16B 179B 1.2B 1.06B 986M 893M 1.68B 113B 1.7B 11.81B 4.63B 59.33B 4.49B 4.39B 189B
Net income 175M 156M 144M 131M 246M 16.51B 249M 1.73B 677M 8.68B 656M 642M 27.64B 182M 162M 150M 136M 256M 17.21B 259M 1.8B 706M 9.04B 684M 669M 28.81B
Net Debt 35.51M 31.62M 29.27M 26.52M 49.89M 3.35B 50.56M 351M 138M 1.76B 133M 130M 5.61B -39.68M -35.33M -32.71M -29.63M -55.74M -3.75B -56.5M -392M -154M -1.97B -149M -146M -6.27B
Projected Income Statement - Annual - Balchem Corporation
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,379
Date Price Change Volume
21/10/26 USD 170.78 -0.49% 342,917
20/10/26 USD 171.62 +0.70% 336,335
19/10/26 USD 170.42 -0.18% 363,498
16/10/26 USD 170.73 +0.12% 197,304
15/10/26 USD 170.53 +0.04% 349,111
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Balchem Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
171.62USD
Average target price
209.25USD
Spread / Average Target
+21.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Balchem Corporation
  1. Stock Market
  2. Stocks
  3. BCPC Stock